PLIN2 and neoplasm: This modification allows the molecular chaperone HSC70 to recognize PLIN2/3, promoting the degradation of lipid droplets (LDs) and PLIN2/3 via the lipophagy pathway, thereby facilitating tumor initiation and progression16.